港股濱海投資升超3%,為連續第二日上升
濱海投資(2886.HK)盤中一度升3.25%報1.27港元,為連續第二日上升。消息面上,在近期國務院國資委公佈的2023年度地方“雙百企業”評估結果中,濱海投資榮獲“優秀”等級。據悉,濱海投資自2020年至今已連續四年入選國務院國資委“雙百企業”。公開資料顯示,濱海投資是一家投資控股公司,業務涉及在中國內地投資建設和經營城市燃氣管道網絡、提供管道安裝及施工服務、供應及提供天然氣、液化石油氣,為工、商業用户和城市居民提供清潔能源。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.